应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVR Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
盘前交易 05-21 06:45:09 EDT
8.62
+0.92
+11.95%
盘前
8.65
+0.03
+0.37%
06:33 EDT
最高
8.65
最低
7.65
成交量
168.21万
今开
7.75
昨收
7.70
日振幅
12.92%
总市值
8.35亿
流通市值
8.08亿
总股本
9,685万
成交额
1,375万
换手率
1.79%
流通股本
9,376万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Anteris Technologies Global Corp宣布终止与V2vmedtech协议下的开发投入
美股速递 · 04-30
Anteris Technologies Global Corp宣布终止与V2vmedtech协议下的开发投入
Anteris Technologies Global Corp 达成重要里程碑 有望加速美国Paradigm试验基地启动
美股速递 · 04-28
Anteris Technologies Global Corp 达成重要里程碑 有望加速美国Paradigm试验基地启动
Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%
美股速递 · 01-21
Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%
Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资
美股速递 · 01-21
Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
美股速递 · 2025-11-27
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
金融界 · 2025-01-09
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
异动解读 · 2024-12-14
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
智通财经 · 2024-12-10
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
加载更多
公司概况
公司名称:
Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。
发行价格:
--
{"stockData":{"symbol":"AVR","market":"US","secType":"STK","nameCN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","latestPrice":8.62,"timestamp":1779307200000,"preClose":7.7,"halted":0,"volume":1682144,"hourTrading":{"tag":"盘前","latestPrice":8.6517,"preClose":8.62,"latestTime":"06:33 EDT","volume":722,"amount":6255.489586000001,"timestamp":1779359589192,"change":0.0317,"changeRate":0.003677,"amplitude":0.013921},"delay":0,"changeRate":0.11948051948051935,"floatShares":93757000,"shares":96849700,"eps":-2.22,"marketStatus":"盘前交易","change":0.92,"latestTime":"05-21 06:45:09 EDT","open":7.75,"high":8.645,"low":7.65,"amount":13754771.214704001,"amplitude":0.129221,"askPrice":9.37,"askSize":100,"bidPrice":8.62,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.22,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779370200000},"marketStatusCode":1,"adr":0,"listingDate":1734066000000,"exchange":"NASDAQ","adjPreClose":8.62,"preHourTrading":{"tag":"盘前","latestPrice":8.6517,"preClose":8.62,"latestTime":"06:33 EDT","volume":722,"amount":6255.489586000001,"timestamp":1779359589192,"change":0.0317,"changeRate":0.003677,"amplitude":0.013921},"postHourTrading":{"tag":"盘后","latestPrice":8.61,"preClose":8.62,"latestTime":"19:43 EDT","volume":21648,"amount":186236.6122,"timestamp":1779320595029,"change":-0.01,"changeRate":-0.00116,"amplitude":0.037123},"volumeRatio":1.4011618686781075,"impliedVol":0.4706,"impliedVolPercentile":0.1084},"requestUrl":"/m/hq/s/AVR","defaultTab":"news","newsList":[{"id":"1117443530","title":"Anteris Technologies Global Corp宣布终止与V2vmedtech协议下的开发投入","url":"https://stock-news.laohu8.com/highlight/detail?id=1117443530","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117443530?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:50","pubTimestamp":1777495816,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会文件显示,Anteris Technologies Global Corp决定停止履行与V2vmedtech合作协议中约定的开发投入义务。这一重大调整标志着双方战略合作关系的重大转变。\n该决议立即生效,公司将重新评估相关医疗技术项目的资源分配方案。此次协议调整预计将对Anteris Technologies Global Corp未来季度的研发支出产生直接影响。\n市场分析师指出,这一决定可能源于公司战略重点的重新定位,或反映其寻求更高效研发路径的考量。投资者将密切关注后续发展,特别是公司是否会寻求新的合作伙伴来推进相关技术开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172929384","title":"Anteris Technologies Global Corp 达成重要里程碑 有望加速美国Paradigm试验基地启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1172929384","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172929384?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:07","pubTimestamp":1777370841,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp(纳斯达克上市/双重上市)近日取得关键进展,这一里程碑事件预计将为该公司在美国启动Paradigm试验基地的筹备工作扫清障碍。\n该突破性进展标志着公司核心临床项目推进至新阶段。试验基地的顺利激活对后续患者入组及数据收集至关重要,有望为结构性心脏病创新疗法的开发注入强劲动力。\n市场观察人士指出,此次里程碑的达成不仅验证了公司的技术执行力,更为其在美国市场的战略布局奠定坚实基础。随着Paradigm试验步入正轨,公司商业化进程或将迎来加速期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185513956","title":"Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185513956","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185513956?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:38","pubTimestamp":1768988293,"startTime":"0","endTime":"0","summary":"Anteris Technologies股价在盘前交易中大幅攀升25.9%,此前该公司公布了2亿美元股票发行的定价细节,并确认获得医疗设备巨头美敦力的战略投资。\n这一重大融资举措不仅为Anteris Technologies注入了强劲的资金支持,更通过与行业领导者美敦力的资本合作,显著提升了市场对其技术前景的信心。投资者对此反应热烈,推动股价出现显著波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDT","LU0208291251.USD","LU0314106906.USD","IE00BFXG1179.USD","LU2089984988.USD","LU2111349929.HKD","BK4566","IE00BQXX3C00.GBP","LU2089284900.SGD","LU2089283258.USD","BK4533","LU0158827948.USD","LU1023059063.AUD","LU0211331839.USD","LU0496365809.HKD","IE00B3PB1722.GBP","BK4588","LU1989764664.SGD","BK4585","LU0320765489.SGD","LU1244550494.USD","LU0162691827.USD","LU2271345857.HKD","LU2023251221.USD","IE00BQXX3D17.EUR","IE00B42XCP33.USD","LU0976567544.SGD","LU1571399168.USD","LU1244550221.USD","IE00BQXX3F31.USD","LU2112291526.USD","LU1983299246.USD","LU0072461881.USD","LU1244550577.SGD","LU1989771016.USD","IE00BVYPNW00.USD","LU2468319806.SGD","LU0158827781.USD","LU0265550359.USD","LU1061106388.HKD","IE000M9KFDE8.USD","LU1116320737.USD","LU0122379950.USD","IE00B3T34201.USD","IE00BDGV0183.EUR","LU0211326755.USD","LU1291159041.SGD","LU1506573853.SGD","LU2028103732.USD","LU0265550946.USD","LU1989764748.USD","LU1057294990.SGD","IE00BGHQF631.EUR","LU0211326839.USD","AVR","BK4082","LU0070302665.USD","LU0432979614.USD","LU1116320901.HKD","IE00BVYPNV92.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102163128","title":"Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1102163128","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102163128?lang=zh_cn&edition=full","pubTime":"2026-01-21 05:02","pubTimestamp":1768942936,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. 近日披露了一项重要资本运作计划。该公司宣布,拟公开市场发行普通股,目标融资规模高达2亿美元。与此同时,全球医疗技术巨头美敦力(Medtronic)已承诺对其进行战略投资,此举将为公司未来发展注入强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109513896","title":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1109513896","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109513896?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:38","pubTimestamp":1764193088,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502870517","title":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502870517","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502870517?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:41","pubTimestamp":1736358102,"startTime":"0","endTime":"0","summary":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09014147279955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179521583","title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1179521583","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179521583?lang=zh_cn&edition=full","pubTime":"2024-12-14 03:34","pubTimestamp":1734118456,"startTime":"0","endTime":"0","summary":"心脏瓣膜公司Anteris Technologies Global (AVR) 在纳斯达克上市首日当日暴跌12.33%,引发市场广泛关注。\nAVR当日在纳斯达克进行首次公开募股,发行价为每股6美元,共募集约8,900万美元资金。但开盘后股价即呈现大跌,盘中一度下探至5.26美元。\n市场分析认为,AVR首次公开募股增发新股导致股票供给激增,短期内形成供给压力拖累股价下跌,同时或有投机资金涌入、出货操作亦加剧了股价震荡。投资者对未来发展前景存在分歧,市场情绪转差致股价重挫。预计供需矛盾在未来将得到缓解,股价震荡将趋于平稳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490065371","title":"澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065371","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490065371?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:45","pubTimestamp":1733816700,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,澳大利亚的人工心脏瓣膜制造商Anteris Technologies周一宣布了其 IPO 条款。该公司计划以每股6.78美元的价格发行1,480万股股票,以筹集1亿美元资金。按照拟议价格,Anteris Technologies的市值将达到2.44亿美元。该公司的股票目前在澳大利亚证券交易所上市,代码为“AVR”。Anteris是一家专注于主动脉狭窄患者的结构性心脏公司。Anteris于2024年2月14日秘密提交了申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AVR","159873"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anteristech.com","stockEarnings":[{"period":"1week","weight":0.3201},{"period":"1month","weight":0.4561},{"period":"3month","weight":0.4965},{"period":"6month","weight":1.4489},{"period":"1year","weight":1.2565},{"period":"ytd","weight":0.7275}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。","exchange":"NASDAQ","name":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","nameEN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing),AVR,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎国际,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股价,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股市,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票价格,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票交易,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票购买,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}